<?xml version="1.0" encoding="UTF-8"?>
<ref id="B112">
 <label>112</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Yazdani</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Edraki</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Badri</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Khoshneviszadeh</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Iraji</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Firuzi</surname>
    <given-names>O.</given-names>
   </name>
  </person-group>
  <article-title>Multi-target inhibitors against Alzheimer disease derived from 3-hydrazinyl 1,2,4-triazine scaffold containing pendant phenoxy methyl-1,2,3-triazole: design, synthesis and biological evaluation</article-title>
  <source>
   <italic toggle="yes">Bioorganic Chemistry</italic>
  </source>
  <year>2019</year>
  <volume>84</volume>
  <fpage>363</fpage>
  <lpage>371</lpage>
  <pub-id pub-id-type="doi">10.1016/j.bioorg.2018.11.038</pub-id>
  <pub-id pub-id-type="other">2-s2.0-85057877743</pub-id>
  <?supplied-pmid 30530107?>
  <pub-id pub-id-type="pmid">30530107</pub-id>
 </element-citation>
</ref>
